pyrroles has been researched along with Neurofibromatosis 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Silva, T; Le Marshall, K; Rischin, A | 1 |
| Camci, C; Kalender, M; Sevinc, A; Sirikci, A; Tutar, E | 1 |
| Angelov, L; Guha, A; McMahon, G; Roncari, L; Salhia, B | 1 |
3 other study(ies) available for pyrroles and Neurofibromatosis 1
| Article | Year |
|---|---|
Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Fibroma; Humans; Middle Aged; Neurofibromatosis 1; Piperidines; Pyrimidines; Pyrroles; Skin Neoplasms | 2019 |
Effect of sunitinib on metastatic gastrointestinal stromal tumor in patients with neurofibromatosis type 1: a case report.
Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Indoles; Liver Neoplasms; Male; Middle Aged; Neurofibromatosis 1; Omentum; Pyrroles; Sunitinib | 2007 |
Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas.
Topics: Angiogenesis Inhibitors; Animals; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Endothelial Growth Factors; Enzyme Inhibitors; Indoles; Lymphokines; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neovascularization, Pathologic; Neurofibromatosis 1; Neurons; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Sarcoma; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |